{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T02:32:56Z","timestamp":1788489176730,"version":"build-2803163510"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.msard.2025.106551","type":"journal-article","created":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T02:04:23Z","timestamp":1748225063000},"page":"106551","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Antibody index (cerebrospinal fluid\/serum) of the Epstein-Barr virus in patients with demyelinating disease"],"prefix":"10.1016","volume":"100","author":[{"given":"Jo\u00e3o Batista","family":"Costa-Neto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Kaefer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thalita de Paula Medeiros Mota","family":"Freitas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Carolina Marques","family":"Ciceri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura Bonai","family":"Casal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bheatriz Souza","family":"Lopes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vicente Mamede de","family":"Arruda-Filho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Antonio Mainardi","family":"de Carvalho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6676-2970","authenticated-orcid":false,"given":"Cl\u00f3vis","family":"Paniz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"285","key":"10.1016\/j.msard.2025.106551_bib0001","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jneuroim.2015.05.021","article-title":"Gender influence in EBV antibody response in multiple sclerosis patients from Kuwait","volume":"15","author":"Al-Temaimi","year":"2015","journal-title":"J. Neuroimmunol"},{"issue":"12","key":"10.1016\/j.msard.2025.106551_bib0002","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1038\/s41577-022-00718-z","article-title":"The immunology of multiple sclerosis","volume":"22","author":"Attfield","year":"2022","journal-title":"Nat. Rev. Immunol."},{"issue":"6578","key":"10.1016\/j.msard.2025.106551_bib0003","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1126\/science.abj8222","article-title":"Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis","volume":"375","author":"Bjornevik","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.msard.2025.106551_bib0004","first-page":"160","article-title":"Epstein\u2013Barr virus as a leading cause of multiple sclerosis: mechanisms and implications","volume":"19","author":"Bjornevik","year":"2023","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.msard.2025.106551_bib0005","series-title":"Aprova o Protocolo Cl\u00ednico e Diretrizes Terap\u00eauticas Da Esclerose M\u00faltipla","article-title":"Secretaria de Aten\u00e7\u00e3o \u00e0 Sa\u00fade. Portaria no 391, de 5 de maio de 2015","year":"2015"},{"issue":"10","key":"10.1016\/j.msard.2025.106551_bib0006","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/S1474-4422(24)00256-4","article-title":"Differential diagnosis of suspected multiple sclerosis: global health considerations","volume":"23","author":"Correale","year":"2024","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.msard.2025.106551_bib0007","unstructured":"CSF Diagnosis Manual, 2023. Euroimmun Medizinesche Labordiagnostika AG."},{"key":"10.1016\/j.msard.2025.106551_bib0008","doi-asserted-by":"crossref","first-page":"726","DOI":"10.3389\/fimmu.2019.00726","article-title":"The cerebrospinal fluid in multiple sclerosis","volume":"10","author":"Deisenhammer","year":"2019","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.msard.2025.106551_bib0009","article-title":"Concordance rate between oligoclonal bands and the kappa index in patients with suspected multiple sclerosis (MS)","volume":"82","author":"Domingues","year":"2024","journal-title":"Arq. Neuropsiquiatr."},{"issue":"8","key":"10.1016\/j.msard.2025.106551_bib0010","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.autrev.2009.02.030","article-title":"B cell characterization and reactivity analysis in multiple sclerosis","volume":"8","author":"Fraussen","year":"2009","journal-title":"Autoimmun. Rev."},{"issue":"7","key":"10.1016\/j.msard.2025.106551_bib0011","doi-asserted-by":"crossref","first-page":"545","DOI":"10.12998\/wjcc.v3.i7.545","article-title":"Treatment strategies for multiple sclerosis: when to start, when to change, when to stop?","volume":"3","author":"Gajofatto","year":"2015","journal-title":"World J. Clin. Cases"},{"issue":"4","key":"10.1016\/j.msard.2025.106551_bib0012","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1590\/S0004-282X2009000600011","article-title":"Study of oligoclonal bands restricted to the cerebrospinal fluid in multiple sclerosis patients in the city of S\u00e3o Paulo","volume":"67","author":"Gama","year":"2009","journal-title":"Arq. Neuropsiquiatr."},{"issue":"2","key":"10.1016\/j.msard.2025.106551_bib0013","doi-asserted-by":"crossref","first-page":"482","DOI":"10.3390\/cells9020482","article-title":"T helper cells: the modulators of inflammation in multiple sclerosis","volume":"9","author":"Kunkl","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.msard.2025.106551_bib0014","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/s41586-022-04432-7","article-title":"Clonally expanded B cells in multiple sclerosis bind EBV EBNA1 and GlialCAM","volume":"603","author":"Lanz","year":"2022","journal-title":"Nature"},{"issue":"20","key":"10.1016\/j.msard.2025.106551_bib0015","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1001\/jama.293.20.2496","article-title":"Temporal relationship between elevation of Epstein-Barr Virus antibody titers and initial onset of neurological symptoms in multiple sclerosis","volume":"293","author":"Levin","year":"2005","journal-title":"J. Am. Med. Assoc."},{"issue":"1","key":"10.1016\/j.msard.2025.106551_bib0016","first-page":"01","article-title":"Brief note on Multiple sclerosis","volume":"8","author":"Mohammadi","year":"2021","journal-title":"J. Mult. Scler (Foster City)"},{"issue":"6","key":"10.1016\/j.msard.2025.106551_bib0017","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.msard.2015.08.004","article-title":"Prevalence of multiple sclerosis in Brazil: a systematic review","volume":"4","author":"Pereira","year":"2015","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"20","key":"10.1016\/j.msard.2025.106551_bib0018","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1001\/jama.2022.14236","article-title":"Whats is Multiple sclerosis?","volume":"328","author":"Revital","year":"2022","journal-title":"J. Am. Med. Assoc."},{"issue":"2","key":"10.1016\/j.msard.2025.106551_bib0019","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","article-title":"Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria","volume":"17","author":"Thompson","year":"2018","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.msard.2025.106551_bib0020","first-page":"1816","volume":"26","author":"Walton","year":"2021"},{"key":"10.1016\/j.msard.2025.106551_bib0021","series-title":"Multiple Sclerosis International Federation. Atlas multiple Sclerosis Resources in the World 2008","first-page":"56","year":"2008"}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034825002937?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034825002937?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T11:40:55Z","timestamp":1762602055000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034825002937"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":21,"alternative-id":["S2211034825002937"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2025.106551","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antibody index (cerebrospinal fluid\/serum) of the Epstein-Barr virus in patients with demyelinating disease","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2025.106551","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"106551"}}